CRISPR

Researchers correcting the genetic causes of disease at the DNA or RNA level make their cases.

Researchers discovered that copper induces cytotoxicity through a distinct pathway termed cuproptosis. This insight guides the use of copper-shuttling drugs to treat copper regulation disorders and opens up new therapeutic applications for cancer.

Implanting brown fat into mice fed a high fat diet helps them lose weight and become glucose tolerant. Will it do the same for humans?

Samira Kiani combines her passion for art and design with synthetic biology to create safer CRISPR-based therapeutics for the future.

CRISPR biosensing technology provides unambiguous pathogen detection.

Improved chemistry may make RNA editing therapies more feasible in humans.

Discover a novel approach to vaccine discovery using CRISPR engineering.

Engineered particles improve the efficiency of base editor delivery.

Researchers are using CRISPR gene editing to restore function of the mutant protein that causes Duchenne muscular dystrophy, a genetic disease that causes muscle degeneration.

An engineer turned biology researcher co-founded a bio-pharma start-up with the goal of using CRISPR to reverse the mutation causing the degenerative muscle disorder Duchenne muscular dystrophy.